| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/07/2011 | EP2363710A1 Isolation and identification of T cells |
| 09/07/2011 | EP2363709A1 Separation of conjugated and unconjugated components |
| 09/07/2011 | EP2363493A1 Novel insertion sites in pox vectors |
| 09/07/2011 | EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/07/2011 | EP2363484A2 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody |
| 09/07/2011 | EP2363468A1 Tumor antigen peptide and use thereof |
| 09/07/2011 | EP2363463A1 Novel baculoviral vector |
| 09/07/2011 | EP2363462A1 Novel baculoviral vector |
| 09/07/2011 | EP2363416A2 Anti-platelet membrane glycoprotein VI monoclonal antibody |
| 09/07/2011 | EP2363409A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies. |
| 09/07/2011 | EP2363406A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363403A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 09/07/2011 | EP2363146A1 Method for inhibiting metastasis in a stem cell fusion model of carcinogenesis |
| 09/07/2011 | EP2363145A1 Pharmaceutical anti-TNF-alpha antibody formulation |
| 09/07/2011 | EP2363144A1 Pharmaceutical anti-TNF-alpha antibody formulation |
| 09/07/2011 | EP2363143A2 MVA expressing modified hiv envelope, gag, and pol genes |
| 09/07/2011 | EP2363141A1 Compsition comprising two oligonucleotides linked directly at their 3'ends wherein at leat one oligonucleotide has an accessible 5'end and the compound further comprising IL-2 used for synergistically stimulating an immune response in a patient. |
| 09/07/2011 | EP2363139A1 Method to increase class I presentation of exogenous antigens by human dendritic cells |
| 09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
| 09/07/2011 | EP2362959A1 Method and system for building a phylogeny from genetic sequences and using the same for recommendation of vaccine strain candidates for the influenza virus |
| 09/07/2011 | EP2362908A1 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/07/2011 | EP2362906A1 Rab6kifl/kif20a epitope peptide and vaccines containing the same |
| 09/07/2011 | EP2362901A1 Improved methods for isolating enveloped virus-based vlps free of infectious agents |
| 09/07/2011 | EP2362783A2 Light targeting molecules and uses thereof |
| 09/07/2011 | EP2362782A1 A vaccinia virus protein a46 peptide and use thereof |
| 09/07/2011 | EP2362781A1 Combination vaccine with acellular pertussis |
| 09/07/2011 | EP2362780A1 Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| 09/07/2011 | EP2362767A2 Formulations of single domain antigen binding molecules |
| 09/07/2011 | EP2021490B1 Anthrax vaccine |
| 09/07/2011 | EP1996625B1 Anti-tat226 antibodies and immunoconjugates |
| 09/07/2011 | EP1954308B1 Stabilizers for freeze-dried vaccines |
| 09/07/2011 | EP1802336B1 Malaria prime/boost vaccines |
| 09/07/2011 | CN1903878B Anti SARS virus human source nature antibody IgG Fab section |
| 09/07/2011 | CN1886158B Pharmaceutical preparation comprising an antibody against the EGF receptor |
| 09/07/2011 | CN1840204B Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 09/07/2011 | CN1561230B Antigenic compositions |
| 09/07/2011 | CN102177179A Treatment of autoimmune and inflammatory disease |
| 09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
| 09/07/2011 | CN102177175A Polyvalent vaccine |
| 09/07/2011 | CN102176922A Pharmaceutical compositions comprising antibodies binding to EBV (Epstein-Barr virus) protein BARF1 |
| 09/07/2011 | CN102176921A Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof |
| 09/07/2011 | CN102176914A VHZ for diagnosis and treatment of cancers |
| 09/07/2011 | CN102176907A Oral vaccines for producing mucosal immunity |
| 09/07/2011 | CN102174534A S. pneumoniae antigens |
| 09/07/2011 | CN102174533A Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 09/07/2011 | CN102174477A Hepatitis A virus strain SH and diploid cell adaptation method thereof |
| 09/07/2011 | CN102174476A Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof |
| 09/07/2011 | CN102174451A Salmonella pullorum attenuated mutant strain S6702 (OmpR) and construction method thereof |
| 09/07/2011 | CN102174444A Method for proliferating H9 subtype avian influenza virus and pasteurella by chick embryos |
| 09/07/2011 | CN102174113A Tag-free tuberculosis fusion protein TB10-TB8 |
| 09/07/2011 | CN102174112A Tag-free tuberculosis fusion protein TB10-Ag85B |
| 09/07/2011 | CN102174111A Human interleukin-2 (IL-2)/Fc fusion protein |
| 09/07/2011 | CN102174108A Internalizing anti-cd74 antibodies and methods of use |
| 09/07/2011 | CN102174105A Antibodies directed to her-3 and uses thereof |
| 09/07/2011 | CN102174091A Truncated and expressed duck plague virus (DPV) recombinant envelope gI protein and preparation method and application thereof |
| 09/07/2011 | CN102174090A Swine-origin influenza A virus head protein and preparation method and application thereof |
| 09/07/2011 | CN102174089A Avian influenza virus head protein as well as preparation method and application thereof |
| 09/07/2011 | CN102174086A Porcine circovirus type 2 recombinant cap protein and subunit vaccine |
| 09/07/2011 | CN102172403A Method for treating interleukin-6 related diseases |
| 09/07/2011 | CN102172400A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 09/07/2011 | CN102172399A YncD gene knock-out vector for saimonella, preparation method thereof and prepared saimonella attenuated vaccine |
| 09/07/2011 | CN102172398A Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 09/07/2011 | CN102172397A In vivo targeting of dendritic cells |
| 09/07/2011 | CN101698100B Listeriosis vaccine and preparation method |
| 09/07/2011 | CN101643509B VEGFR-2 resistant monoclonal antibody with human and mouse cross reaction as well as preparation method and application thereof |
| 09/07/2011 | CN101629182B Eukaryotic expression plasmid of chicken defensin-1 gene and molecular adjuvants prepared by the gene and vaccine |
| 09/07/2011 | CN101407546B Human anti-human tumor necrosis factor-alpha single chain antibody |
| 09/07/2011 | CN101314035B Uses of biological polyoses microcapsule |
| 09/07/2011 | CN101230103B Human recombinant anti-IgE antibody |
| 09/07/2011 | CN101151020B Adjuvanting material |
| 09/06/2011 | US8013135 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 09/06/2011 | US8013128 Antibodies and related molecules that bind to PSCA proteins |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8013123 Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| 09/06/2011 | US8012947 Methods and compositions for promoting wound healing |
| 09/06/2011 | US8012937 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 09/06/2011 | US8012935 Oligopeptide for blocking cancer |
| 09/06/2011 | US8012932 Contraceptives based on SP22 and SP22 antibodies |
| 09/06/2011 | US8012754 Antibody compositions |
| 09/06/2011 | US8012750 T-cell activation device |
| 09/06/2011 | US8012738 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
| 09/06/2011 | US8012737 Methods of producing influenza vaccine compositions |
| 09/06/2011 | US8012736 Multi plasmid system for the production of influenza virus |
| 09/06/2011 | US8012716 Animal protein-free medium; making and purifying botulinum toxin |
| 09/06/2011 | US8012707 MN gene and protein |
| 09/06/2011 | US8012679 Papillomavirus vaccines |
| 09/06/2011 | US8012505 A non-compressed, fast-dispersing solid dosage form suitable for oromucosal administration; maltodextrin having a dextrose equivalent (DE) of between 1 and 20, sorbitol, and the drug; improved storage stability and mechanical strength |
| 09/06/2011 | US8012493 Malaria vaccines |
| 09/06/2011 | US8012492 In vitro model of latent mycobacterial infection |
| 09/06/2011 | US8012491 Recombinant toxin fragments |
| 09/06/2011 | US8012490 Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents |
| 09/06/2011 | US8012489 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 09/06/2011 | US8012488 Polyoxyalkylene derivative |
| 09/06/2011 | US8012487 Amino acid sequence comprising immunogenic epitope cluster for use as tool in diagnosis and treatment of autoimmune disorders |
| 09/06/2011 | US8012486 Composition for treating atopic dermatitis comprising hirsutenone as an active ingredient |
| 09/06/2011 | US8012485 Drug conjugate composition |
| 09/06/2011 | US8012484 Using immunoglobulins which inhibit natural killer cell activity as therapeutic agents in prevention and treatment of ischemic injury; antitumor agents; adenosine receptor agonist |
| 09/06/2011 | US8012483 Phosphorylcholine conjugates and corresponding antibodies |